A new citrated formulation of nalidixic acid (Mictral U.K.) for the treatment of acute cystitis
Dulake, C.; Adam, G.; Allenby, F.; Anderson, A.R.; Clark-Jones, A.; Cure, S.M.
Journal of International Medical Research 9(3): 177-180
1981
ISSN/ISBN: 0300-0605 PMID: 7016625 Document Number: 172881
A 3-day course of a new citrated formulation of nalidixic acid (Mictral) was assessed in 54 women presenting with acute uncomplicated cystitis. Over 96% of women with a significant Gram-negative bacteriuria were cured of the infection following a course of treatment. Only 2 relapses occurred in this group during the follow-up period. Relief of symptoms occurred in nearly 90% of infected patients and generally by the second day of treatment. Although the incidence of side effects was about 20%, they were not considered serious.